Yale New Haven Health CEO O’Connor details tough year, restructuring and plans for recovery
Yale New Haven Health posted a $40M operating loss through Q3 amid rising costs and $63M in settlements. The CEO...
Yale New Haven Health posted a $40M operating loss through Q3 amid rising costs and $63M in settlements. The CEO...
Menaka Sarav, MD, uses the latest research in kidney nutrition to help individuals with all stages of kidney disease. At...
In Samit Shah’s second year as a faculty member of the Yale School of Medicine (YSM), he applied for a...